Determination of citalopram and escitalopram together with their active main metabolites desmethyl(es-)citalopram in human serum by column-switching high performance liquid chromatography (HPLC) and spectrophotometric detection

Greiner, Christine and Hiemke, Christoph and Bader, Wolfgang and Haen, Ekkehard (2007) Determination of citalopram and escitalopram together with their active main metabolites desmethyl(es-)citalopram in human serum by column-switching high performance liquid chromatography (HPLC) and spectrophotometric detection. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 848 (2). pp. 391-394. ISSN 1570-0232,

Full text not available from this repository. (Request a copy)

Abstract

We established a method for automated quantitative analysis of (es-)citalopram and desmethyl(es-)citalopram in serum using column-switching high performance liquid chromatography (HPLC). For sample clean-up serum was injected onto a LiChrospher CN 20 mu m precolumn using 8% acetonitrile in deionized water. Drugs were eluted by back-flush flow onto the analytical column (LiChrospher CN 5 mu m) at a flow rate of 1.5 ml/min with phosphate buffer 8 mmol/l pH 6.4/acetonitrile (50/50, v/v). Haloperidol was used as internal standard. Analytes were detected by ultraviolet spectrophotometry at 210 nm. Detection limit of (es-)citalopram was 6 ng/ml. The method was found to be suitable for therapeutic drug monitoring of patients treated with citalopram or escitalopram. (c) 2006 Elsevier B.V. All rights reserved.

Item Type: Article
Uncontrolled Keywords: PLASMA; QUANTIFICATION; FLUOXETINE; citalopram; escitalopram; quantitative analysis; HPLC column-switching; TDM
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Psychiatrie und Psychotherapie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 16 Dec 2020 11:02
Last Modified: 16 Dec 2020 11:02
URI: https://pred.uni-regensburg.de/id/eprint/32961

Actions (login required)

View Item View Item